Teza Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,026
| Closed | -$602K | – | 571 |
|
|
2024
Q1 | $602K | Sell |
4,026
-7,396
| -65% | -$1.11M | 0.08% | 309 |
|
|
2023
Q4 | $2.19M | Buy |
+11,422
| New | +$2.19M | 0.37% | 71 |
|
|
2023
Q2 | – | Sell |
-1,735
| Closed | -$348K | – | 559 |
|
|
2023
Q1 | $348K | Buy |
+1,735
| New | +$348K | 0.08% | 352 |
|
|
2020
Q3 | – | Sell |
-7,437
| Closed | -$1.1M | – | 362 |
|
|
2020
Q2 | $1.1M | Buy |
7,437
+5,433
| +271% | +$804K | 0.24% | 123 |
|
|
2020
Q1 | $218K | Sell |
2,004
-717
| -26% | -$78K | 0.7% | 66 |
|
|
2019
Q4 | $313K | Buy |
+2,721
| New | +$313K | 0.09% | 412 |
|